SDG 3 Newsletter: Substance Use

Substance use (abuse) is a nuanced and often misunderstood topic, but one that can have huge implications on those using (abusing) said substances. In this issue of the SDG 3 newsletter we hope to dispel some of the myths and stigmas surrounding substance use and present alternative outlooks.
SDG 3 Newsletter: Substance Use
Like

Share this post

Choose a social network to share with, or copy the URL to share elsewhere

This is a representation of how your post may appear on social media. The actual post will vary between social networks

This newsletter primarily champions SDG 3.5, Substance Abuse.

Psychoactive substance use: time to rethink? 

As interest grows in the therapeutic potential of substances like cannabis, ketamine and psilocybin, can clinical trial registries help separate evidence from hype and provide a more balanced understanding of their benefits and risks? 

A needle, white powder and various tablets

National Overdose Awareness Day

International Overdose Awareness Day 2025: One big family, driven by hope | AlphaBiolabs UKIn honour of National Overdose Awareness Day on August 31, this blog discusses the successes and struggles of overdose prevention initiatives in the United States.

Role of Primary care in Relapse and recovery

Relapse in substance use disorders is increasingly understood not as failure but as a manageable, chronic condition, with new evidence showing that primary care can reduce recurrence through early screening, stigma‑free support, lifestyle counseling, and integration of mental health, social networks, and nutrition into routine care.

Global Perspectives on Chemsex in LGBTQ+ Health

This collection in Global LGBTQ+ Health highlights the need for more inclusive and globally representative understandings of chemsex, bringing together research on sexualised drug use, health and wellbeing, harm reduction, community care, and the diverse lived experiences of LGBTQ+ people across different social and cultural contexts.

Meet the Editor: Dr Rayner Kay Jin Tan

What are the biggest priorities in LGBTQ+ health research today? Meet Deputy Editor Dr Rayner Kay Jin Tan as he discusses equity, representation, and the importance of highlighting emerging areas such as chemsex research.

 

Integrated Perinatal and Postnatal Strategies for Infants with Prenatal Substance Exposure

This collection in Maternal Health, Neonatal and Perinatology highlights the growing need for integrated, family-centred approaches to support infants with prenatal substance exposure and their mothers, bringing together research on neonatal care, developmental outcomes, and multidisciplinary models that improve long-term health and wellbeing.

Substance use in dentistry

This blog posts draws together content from across the BDJ Portfolio to highlight how substance use in dentistry doesn't solely affect patients but amongst dental professionals too.

Mercury-Free Dentistry in North York | Mercury-Free Dentistry Near You


In Other News...

Nutraceuticals collection

This collection from the European Journal of Applied Physiology explores the use of nutraceutical supplements in sports. Although frequently utilized to enhance performance and improve muscle and whole-body recovery, there is often a deficiency of high-quality, evidence-based research supporting their function and safety.

Substance use disorders and addictions

In this collection from Scientific Reports substance use disorders (SUDs) refer to mental disorders, whereby affected individuals are unable to control their use of substances, such as nicotine, alcohol, drugs, or specific medications. SUDs and related addictions are a major public health concern, affecting people’s health and well-being at all ages.

The baffling science of SSRIs

The world’s most popular antidepressant drugs are under fire. But are they really harder to quit than heroin? Read more in this Nature news feature.

E-cigarettes and the comparative politics of harm reduction

In this interview (part of a series from the OA books group) Co-Editor, Virginia Berridge, of the OA Book E-cigarettes and the comparative politcs of harm reduction, discusses the first in-depth study of the history and current debates surrounding electronic cigarettes comparing the UK, US and Australia.

SDG 5 Breaking Barriers

After two years, Breaking Barriers for Gender Rights and Justice through Research returns this September for the third edition of Springer Nature's free virtual conference exploring progress, challenges, and opportunities related to SDG 5: Gender Equality.



Get involved!

If you would like to be involved with our SDG 3 initiatives, contact me or Amy Joint. Follow me, Virginia Mercer, and Amy Joint on Research Communities to be notified of future SDG 3 newsletters.

With special thanks to this newsletter's contributors: Emma Campbell, Sophie Gray, Amy Joint, Tamara May, Rita Moreira, Eshita Paul, Priya Sharma, Danielle Yates.

Please sign in or register for FREE

If you are a registered user on Research Communities by Springer Nature, please sign in

Follow the Topic

SDG 3: Good Health & Wellbeing
Research Communities > Community > Sustainability > UN Sustainable Development Goals (SDG) > SDG 3: Good Health & Wellbeing
Substance Abuse Disorder
Humanities and Social Sciences > Behavioral Sciences and Psychology > Clinical Psychology > Mental Disorder > Substance Abuse Disorder
Social Sciences
Humanities and Social Sciences > Social Sciences
Public Health
Life Sciences > Health Sciences > Public Health

Related Collections

With Collections, you can get published faster and increase your visibility.

Phytochemicals and health

This Collection welcomes original research investigating the mechanisms underlying phytochemical health effects, therapeutic potential, and challenges related to bioavailability and clinical application.

Publishing Model: Open Access

Deadline: Oct 28, 2026

Novel Interventions to Improve Survival in Preterm Neonates

This Collection focuses on a topic central to every neonatologist’s practice: highlighting recent advances, interventions, and protocols that improve intact survival among neonates born at less than 37 weeks’ gestational age. Because these infants require highly specialized care, management strategies used for more mature neonates often cannot be directly applied. This Collection aims to showcase how care differs for this vulnerable population and to emphasize the innovations that are reshaping preterm neonatal management.

A particular emphasis is placed on management strategies and scalable care models suitable for low-resource settings. The Collection will critically examine current practices in neonatal intensive care units across diverse global contexts and explore the reforms needed to optimize outcomes for preterm infants. The emerging role of artificial intelligence in guiding the management of these neonates will also be addressed.

Neonatal mortality represents a substantial proportion of under-five mortality worldwide, with prematurity as a leading contributor. Accordingly, this issue will highlight not only postnatal treatment strategies, but also antenatal preventive approaches aimed at reducing the incidence of prematurity and improving the likelihood of neurologically intact survival when preterm birth does occur.

By integrating these various strategies and focusing on both preventive and therapeutic intervention points, this issue seeks to provide a comprehensive overview of current practices, advancements, and future research opportunities in the care of this high‑risk subgroup of neonates.

This Collection supports and amplifies research related to SDG 3: Good Health and Well-Being.

All submissions in this Collection undergo the journal’s standard peer review process, and all manuscripts authored by a Guest Editor(s) are handled by the Editor-in-Chief. As an open access publication, this journal levies an article processing fee (details here). We recognize that many key stakeholders may not have access to such resources and are committed to supporting participation in this issue wherever resources are a barrier. For more information about what support may be available, please visit OA funding and support, or email OAfundingpolicy@springernature.com or the Editor-in-Chief.

Publishing Model: Open Access

Deadline: Jan 08, 2027